Literature DB >> 11309035

Allergic contact dermatitis to cinchocaine.

C R Kearney1, J Fewings.   

Abstract

A case of allergic contact dermatitis to cinchocaine is presented to highlight the confusion regarding the classification of, and cross-reactivity between, topical anaesthetic agents and the inadequacy of the use of benzocaine as a single screening agent for topical anaesthetic contact allergy. Our patient presented with a 10-day history of acute perianal dermatitis. Allergic contact dermatitis to Proctosedyl ointment, which was applied for 3 weeks prior, was suspected. On patch testing, he reacted to cinchocaine, a constituent of Proctosedyl ointment, and to the actual product, but had no reaction to benzocaine or lignocaine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309035     DOI: 10.1046/j.1440-0960.2001.00493.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  4 in total

1.  [Topical therapy of perianal eczema].

Authors:  J Schauber
Journal:  Hautarzt       Date:  2010-01       Impact factor: 0.751

2.  [Relevant allergans by periorbital allergic contact dermatitis. Oxybuprocain, an underestimated allergen].

Authors:  V Blaschke; T Fuchs
Journal:  Ophthalmologe       Date:  2003-08       Impact factor: 1.059

3.  Allergic Contact Dermatitis and Autoeczematization to Proctosedyl® Cream and Proctomyxin® Cream.

Authors:  J D Matthew Hughes; Melanie D Pratt
Journal:  Case Rep Dermatol       Date:  2018-10-24

Review 4.  Therapeutic management of anal eczema: an evidence-based review.

Authors:  B Havlickova; G H Weyandt
Journal:  Int J Clin Pract       Date:  2014-06-04       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.